QUOTE AND NEWS
FierceBiotech  Jul 20  Comment 
Sanofi Genzyme's and Novartis’ venture arms have backed NeuroVia, an upstart that wants to help treat the rare CNS disorder X-linked adrenoleukodystrophy.
GenEng News  Jul 19  Comment 
A chimeric antigen receptor T-cell (CAR-T) therapy for glioblastoma (GBM) successfully crossed the blood–brain barrier to reach tumors in the brain, appeared safe, and reduced levels of its epidermal growth factor variant III (EGFRvIII) tumor...
FiercePharma  Jul 19  Comment 
Amid a noted slowdown in biopharma M&A, fresh comments from Novartis CEO Joe Jimenez signal the challenges facing the industry’s dealmakers. Namely, too-high biotech valuations have forced the Swiss drugmaker's M&A scouts to eye earlier-stage...
Financial Times  Jul 18  Comment 
Drugmaker is exploring whether to spin out Alcon division
FiercePharma  Jul 18  Comment 
Two words and an exclamation point summed up Novartis’ second-quarter earnings surprise: “Alcon grew (!),” declared Bernstein analyst Tim Anderson. The drugmaker needed that unexpected boost from its struggling eye business, because generics...




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki